tiprankstipranks
Tristel PLC (GB:TSTL)
LSE:TSTL

Tristel Stock Analysis & Ratings

GB:TSTL Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range270.00p - 660.07p
Previous Close342.5p
Volume6.63K
Average Volume (3M)87.74K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-303.4
Beta0.35
Next EarningsOct 19, 2022
EPS ForecastN/A
Dividend Yield0.05 (1.91%)
1Y Price TargetN/A
Smart Score6


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:TSTL FAQ

What was Tristel’s price range in the past 12 months?
Tristel lowest stock price was 270.00p and its highest was 660.07p in the past 12 months.
    What is Tristel’s market cap?
    Currently, no data Available
    What is Tristel’s price target?
    Currently, no data Available
    What do analysts say about Tristel?
    Not enough analysts have published a price target to provide an average price target.
    When is Tristel’s upcoming earnings report date?
    Tristel’s upcoming earnings report date is Oct 19, 2022 which is in 105 days.
      How were Tristel’s earnings last quarter?
      Tristel released its earnings results on Feb 21, 2022. The company reported 2.5p earnings per share for the quarter, beating the consensus estimate of N/A by 2.5p.
        Is Tristel overvalued?
        According to Wall Street analysts Tristel’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Tristel pay dividends?
          Tristel pays a Annually dividend of 2.62p which represents an annual dividend yield of 1.91%. Tristel’s last Annually dividend payment was on Apr 01, 2022. Tristel’s upcoming ex-dividend date is Apr 07, 2022
            What is Tristel’s EPS estimate?
            Tristel’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Tristel have?
            Tristel has 47,224,995 shares outstanding.
              What happened to Tristel’s price movement after its last earnings report?
              Tristel reported an EPS of 2.5p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -19.76%.
                Which hedge fund is a major shareholder of Tristel?
                Currently, no hedge funds are holding shares in GB:TSTL

                ---

                Tristel Stock Analysis

                Smart Score
                6
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                Price Target
                No data currently available

                Analyst Forecast

                N/A
                Currently Not Enough Data Available

                Blogger Sentiment

                N/A
                Currently Not Enough Data Available

                Insider Transactions

                ▲ Bought Shares
                Worth £19.5K over the Last 3 Months

                News Sentiment

                N/A
                Currently Not Enough Data Available

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -46.11%
                12-Months-Change

                Fundamentals

                Return on Equity
                5.53%
                Trailing 12-Months
                Asset Growth
                -8.47%
                Trailing 12-Months
                The Tristel Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Tristel PLC

                Tristel PLC is a player in the healthcare platform. The company is a manufacturer of infection prevention and contamination control products. Its core product candidate is a chlorine dioxide formulation. Its operating segments include Hospital medical device decontamination and Hospital environmental surface disinfection. It caters to three market avenues: The Human Healthcare market, The Contamination Control market, and the Animal Healthcare market. The Human Healthcare division deals with hospital infection prevention and accounts for most of the company's revenues.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Bioventix
                Advanced Medical Solutions
                Inland Homes
                Trifast
                AB Dynamics

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis